Labor Market Pulse · Human Resources · August 2026
Human Resources Labor Market Report: Philadelphia-Camden-Wilmington, PA-NJ-DE-MD MSA — August 2026
Philly Wages Lag While Benefit Costs Outpace Growth
Philadelphia's compensation costs rose only 3.1% in wages and salaries through June 2026 — trailing New York and the national pace — while employer health benefit costs are on track to climb 6.7% this year, pushing total rewards budgets into structurally tighter territory even as the metro's unemployment rate holds above 5%.
Free archive edition. Published by WageScape as sent to subscribers; data as of August 2026.
Key indicators
- Philly metro unemployment rate: ~5.0% — vs. 4.1% national average, Aug 2026 (BLS)
- Philly compensation cost growth: 3.3% — vs. 3.4% national ECI, year ending June 2026
- Employer health benefit cost rise: 6.7% — Projected 2026 avg cost >$18,500/employee (Mercer)
- Philly Fed Manufacturing Index: 47.4 — Five-year high; employment sub-index at 4-yr high
Key takeaways
HRIS Analyst pay gap is a talent access problem, not a cost advantage.
Advertised pay for HRIS Analyst in the Philadelphia metro sits at $83,911 — more than $11,700 below the national median of $95,665, which is itself trending upward. As employers nationwide accelerate HRIS modernization and AI-integrated HR platforms, local pay positioning at this level may constrain candidate quality and extend time-to-fill, rather than simply reflecting lower local market cost.
Rising benefit costs are consuming wage budget before compensation leaders notice.
National employer health benefit costs are projected to rise 6.7% in 2026 — outpacing wage growth of 3.1% — pushing the average cost above $18,500 per employee. For Philadelphia organizations running tight total rewards budgets against already-lagging wage growth, the math increasingly forces a choice between absorbing benefit cost inflation, shifting costs to employees, or slowing base pay movement; current conditions suggest that choice deserves explicit strategy, not a default.
Compensation Analyst pay is declining locally while holding nationally — a benchmarking signal.
Local advertised median for Compensation Analyst is down significantly at $89,918, while the national median holds at $101,055. This divergence may reflect a thinner posting market or employer anchoring to older ranges; either way, it creates a meaningful gap at exactly the function responsible for setting market-competitive pay strategy across the organization.
Philadelphia's manufacturing surge is quietly tightening the skilled labor pool.
The Philadelphia Fed's August Manufacturing Business Outlook Survey general activity index jumped to 47.4 — a five-year high — with the employment index reaching its highest point since April 2022. A simultaneous expansion in manufacturing hiring and life sciences demand puts pressure on a technical talent pool that is already constrained, with downstream implications for workforce planning in operations, quality, and HRIS functions that support those sectors.
Median advertised pay by role — Philadelphia-Camden-Wilmington, PA-NJ-DE-MD MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Compensation Analyst | $73,700 | $89,918 | $102,517 | Significant decline | $101,055 |
| HR Business Partner | $61,583 | $82,471 | $94,984 | Stable | $83,180 |
| Benefits Manager | $90,000 | $122,351 | $124,583 | Stable | $120,000 |
| HRIS Analyst | $71,954 | $83,911 | $98,800 | Significant decline | $95,665 |
| HR Coordinator | $41,600 | $49,903 | $56,160 | Significant increase | $50,095 |
| Recruiter | $51,727 | $66,553 | $76,907 | Stable | $67,643 |
| Payroll Specialist | $51,823 | $64,000 | $70,000 | Moderate increase | $58,266 |
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Philadelphia's labor market is softening at the margins even as it avoids outright contraction: new unemployment claims rose 19.7% year-over-year through Q1 2026, driven overwhelmingly by layoffs and terminations, while the city unemployment rate held near 5.0% — roughly a full percentage point above the national rate of 4.1%. Hiring demand remains concentrated in the metro's eds-and-meds core, with healthcare and social assistance accounting for 27% of local employment and life sciences demand intensifying around the Greater Philadelphia cell and gene therapy cluster, but broader private-sector wage growth at 3.1% over the year ending June 2026 continues to trail both New York (3.1% nominal match but higher absolute levels) and the national pace, compressing real purchasing power for the fourth consecutive year.
What it means
A market where labor supply is rising modestly but wage growth lags the national average creates a deceptive sense of slack: candidates are more available, but advertised pay rates for critical technical roles — particularly HRIS Analyst, where local median advertised pay trails the national figure by more than $11,000 — signal that Philadelphia employers may be underpricing against a market that has moved. Organizations should evaluate whether posted pay ranges for technology-adjacent HR and compensation roles reflect current national market rates rather than local historical anchors, particularly before Q4 headcount planning cycles open.
Looking ahead
Emerging pressure point: Pennsylvania's Q3 initial claims data, expected in October, will indicate whether the 19.7% year-over-year surge in unemployment claims seen through Q1 has continued or stabilized. If layoff-driven claims remain elevated into the fall, HR leaders should anticipate a modest influx of mid-career candidates — particularly from healthcare administration and staffing — that could temporarily soften advertised pay pressure in select roles.
Potential inflection point: The Fed's September Employment Cost Index release (due October 30) will be the first read on whether the Q2 benefit cost acceleration — 3.8% nationally, outpacing wage growth — has continued into the second half. For Philadelphia employers mid-cycle on benefits renewals, this figure will directly inform whether current plan design is competitive or already losing ground against peer employers adjusting cost-sharing structures.
Worth watching: Philadelphia's cell and gene therapy corridor — anchored by Penn Medicine, CHOP, Spark Therapeutics, Iovance, and Cabaletta Bio — continues to attract hiring demand for highly specialized manufacturing and regulatory talent, with Director-level CGT roles averaging 100 to 120 days to fill. HR leaders in life sciences and healthcare anchor institutions should monitor whether this competition begins pulling HR and total rewards talent along with clinical operations staff, tightening the pool for compensation benchmarking and HRIS functions.
Early indicator: Philadelphia's manufacturing activity index reaching a five-year high in August suggests near-term headcount expansion among Third District industrial employers, with the forward activity index jumping to 73.6. If that hiring materializes, it may compete directly with healthcare and life sciences for technician and operations-adjacent talent — an early signal for workforce planners tracking cross-sector labor availability in the metro.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.